NCT07101250View on ClinicalTrials.gov

Preoperative Acetazolamide

PHASE4Not yet recruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

September 15, 2025

Primary Completion Date

August 1, 2026

Study Completion Date

November 1, 2026

Conditions
Post Operative PainLaparoscopic HysterectomyReferred Pain
Interventions
DRUG

Acetazolamide 500 MG Extended Release Oral Capsule

Active Drug

DRUG

Placebo

Inactive Drug

Trial Locations (1)

29605

Prisma Health, Greenville

All Listed Sponsors
lead

Prisma Health-Upstate

OTHER

NCT07101250 - Preoperative Acetazolamide | Biotech Hunter | Biotech Hunter